The European Tech Tour Association, an independant, not-for-profit organization committed to the development of emerging technology companies from Europe, announced that it has selected Occlutech to receive the 2012 Excellence in Medtech Award.
The award was presented at the gala dinner of the 2012 European MedTech Summit in Lausanne, Switzerland by Dr. Brian Hashemi, Managing Partner of Salus Partners who announced: "Occlutech represents excellence in the development of innovative technologies in the area of minimally invasive cardiac occlusion. Innovative devices such as Patent Foramen Ovale occlusion have improved therapy in this fast advancing field bringing significant health benefits to thousands of patients around the world."
Tor Peters, Occlutech's founder and CEO says; "This recognition means a lot to Occlutech, our employees, our suppliers, and our customers, all of whom have supported us tremendously over the past years. Building a company is teamwork and I am very grateful to the team, including customers and opinion leaders who have supported us in making this possible."
Occlutech, (http://www.occlutech.com) is a leading developer of products for minimally invasive cardiac occlusion and intervention with manufacturing and development in several European countries.
Salus Partners, (http://www.saluspartners.com) is a leading Swiss advisory firm providing services in the areas of wealth optimization, healthcare investments and corporate services.
The European Tech Tour Association, (http://www.techtour.com) is an independent, not-for profit organization composed of key contributors to the high-technology industry. The association recognizes that continued prosperity in Europe lies in its ability to transform today's innovative projects into tomorrow's global technology leaders.
Source: Occlutech
For information please contact : Tor Peters, tor.peters@occlutech.com; Susanne Göransson susanne.goransson@occlutech.com, +46(0)42-33-65-21
Editor: PR Wire
Copyright © ANTARA 2012
